Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SHANGHAI, China, July 13, 2016 (GLOBE NEWSWIRE) -- China Lodging Group, Limited (NASDAQ:HTHT) (“China Lodging Group” or the “Company”), a leading and fast-growing multi-brand hotel group in China,...
-
WALTHAM, Mass., July 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drugs for...
-
WALTHAM, Mass., June 29, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd., a clinical-stage biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drugs for the treatment...
-
BEIJING, June 29, 2016 (GLOBE NEWSWIRE) -- JD.com (Nasdaq:JD), China’s largest e-commerce company by revenue, today announced the launch of British Mall, a special channel on JD.com’s online...
-
SHANGHAI, China, June 29, 2016 (GLOBE NEWSWIRE) -- China Lodging Group, Limited (NASDAQ:HTHT) (“China Lodging Group” or the “Company”), a leading and fast-growing multi-brand hotel group in China,...
-
BEIJING, June 23, 2016 (GLOBE NEWSWIRE) -- International soccer icon and China Super League star Tim Cahill has announced he will enter the China fashion market for the first time, launching his...
-
BEIJING, June 21, 2016 (GLOBE NEWSWIRE) -- JD.com (Nasdaq:JD), China’s largest e-commerce company by revenue, today announced that it will host a week-long roadshow of “British Week” activities in...
-
BEIJING, June 13, 2016 (GLOBE NEWSWIRE) -- JD.com (Nasdaq:JD), China’s largest online direct sales company, today announced that the Group Zannier, the global leader in children’s fashion, will...
-
WALTHAM, Mass., June 06, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (Nasdaq:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology...
-
WALTHAM, Mass., June 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and...